Deutsche Bank Ag\ Design Therapeutics, Inc. Transaction History
Deutsche Bank Ag\
- $212 Billion
- Q1 2024
A detailed history of Deutsche Bank Ag\ transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 28,094 shares of DSGN stock, worth $94,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,094
Previous 28,094
-0.0%
Holding current value
$94,114
Previous $74,000
52.7%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DSGN
# of Institutions
95Shares Held
30.5MCall Options Held
100Put Options Held
100-
Sr One Capital Management, LP6.53MShares$21.9 Million8.85% of portfolio
-
Logos Global Management LP San Francisco, CA5.03MShares$16.9 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.27MShares$7.62 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.66MShares$5.57 Million0.08% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$4.96 Million0.73% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $187M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...